# Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)

> **NCT04409873** · PHASE2 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 54 (actual)

## Conditions studied

- COVID-19
- SARS-CoV 2
- Severe Acute Respiratory Syndrome Coronavirus 2
- Virus Disease
- Coronavirus Infections
- Pharyngeal Diseases

## Interventions

- **DRUG:** Oral-B Mouth Sore mouthwash
- **DRUG:** Crest Pro-Health Multi-Protection mouthwash
- **DRUG:** CloSYS Ultra Sensitive Rinse mouthwash
- **DRUG:** Distilled water
- **DRUG:** Listerine Zero Mouthwash Product

## Key facts

- **NCT ID:** NCT04409873
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-31
- **Primary completion:** 2022-09-10
- **Final completion:** 2022-09-10
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** The funder decided not to continue funding, causing enrollment to cease prematurely and curtailing originally planned analyses. Participants with any samples collected after the baseline pre-rinse samples were included in the analysis.
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04409873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04409873, "Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04409873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*